Skip to main content
PMC home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1994 Aug;70(2):285–288. doi: 10.1038/bjc.1994.293

Improved prognosis of breast cancer since 1970 in south-eastern Netherlands.

H W Nab 1, W C Hop 1, M A Crommelin 1, H M Kluck 1, J W Coebergh 1
PMCID: PMC2033497  PMID: 8054277

Abstract

Despite many new advances in breast cancer therapy since the 1970s, there are only few reports on improved prognosis in a general population. A follow-up of more than 10 years is rarely reported, and a differentiation according to stage of the disease or between follow-up intervals is seldom made. Our purpose was to assess whether prognosis of primary breast cancer improved in patients diagnosed between 1970 and 1984 in south-eastern Netherlands, and to distinguish between different stages and follow-up intervals. Data from 4,467 breast cancer patients diagnosed between 1970 and 1984 were derived from the population-based Eindhoven Cancer Registry. Follow-up was attained up to 1 July 1991. Relative survival rates, as the ratio of the observed to the expected rates, were calculated. In a multivariate analysis a change in prognosis over time was computed with adjustment for age and stage; this was done separately for 5 year follow-up intervals. The relative survival rates were 69% after 5 years, 55% after 10 years and 50% after 20 years. Relative survival, after adjustment for age, was strongly related to the stage of the disease in the first 5 years of follow-up, less markedly between 5 and 10 years, and to a small, borderline significant, extent after 10 years of follow-up. Relative survival rates increased markedly over time, during the whole interval of follow-up. This increase was apparent in all age groups and in all stages, except for those with distant disease at diagnosis. The observed improvement in survival is unlikely to be explained by the increased use of adjuvant chemo- and hormonal therapy. Other factors, such as a change in the natural history of the disease in this period, cannot be ruled out.

Full text

PDF
285

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. A'Hern R. P., Ebbs S. R., Baum M. B. Does chemotherapy improve survival in advanced breast cancer? A statistical overview. Br J Cancer. 1988 Jun;57(6):615–618. doi: 10.1038/bjc.1988.140. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Adami H. O., Malker B., Rutqvist L. E., Persson I., Ries L. Temporal trends in breast cancer survival in Sweden: significant improvement in 20 years. J Natl Cancer Inst. 1986 Apr;76(4):653–659. doi: 10.1093/jnci/76.4.653. [DOI] [PubMed] [Google Scholar]
  3. BERKSON J., GAGE R. P. Calculation of survival rates for cancer. Proc Staff Meet Mayo Clin. 1950 May 24;25(11):270–286. [PubMed] [Google Scholar]
  4. Black W. C., Welch H. G. Advances in diagnostic imaging and overestimations of disease prevalence and the benefits of therapy. N Engl J Med. 1993 Apr 29;328(17):1237–1243. doi: 10.1056/NEJM199304293281706. [DOI] [PubMed] [Google Scholar]
  5. Clark R. M., McCulloch P. B., Levine M. N., Lipa M., Wilkinson R. H., Mahoney L. J., Basrur V. R., Nair B. D., McDermot R. S., Wong C. S. Randomized clinical trial to assess the effectiveness of breast irradiation following lumpectomy and axillary dissection for node-negative breast cancer. J Natl Cancer Inst. 1992 May 6;84(9):683–689. doi: 10.1093/jnci/84.9.683. [DOI] [PubMed] [Google Scholar]
  6. Danforth D. N., Jr, Findlay P. A., McDonald H. D., Lippman M. E., Reichert C. M., d'Angelo T., Gorrell C. R., Gerber N. L., Lichter A. S., Rosenberg S. A. Complete axillary lymph node dissection for stage I-II carcinoma of the breast. J Clin Oncol. 1986 May;4(5):655–662. doi: 10.1200/JCO.1986.4.5.655. [DOI] [PubMed] [Google Scholar]
  7. Feinstein A. R., Sosin D. M., Wells C. K. The Will Rogers phenomenon. Stage migration and new diagnostic techniques as a source of misleading statistics for survival in cancer. N Engl J Med. 1985 Jun 20;312(25):1604–1608. doi: 10.1056/NEJM198506203122504. [DOI] [PubMed] [Google Scholar]
  8. Fisher B., Redmond C., Poisson R., Margolese R., Wolmark N., Wickerham L., Fisher E., Deutsch M., Caplan R., Pilch Y. Eight-year results of a randomized clinical trial comparing total mastectomy and lumpectomy with or without irradiation in the treatment of breast cancer. N Engl J Med. 1989 Mar 30;320(13):822–828. doi: 10.1056/NEJM198903303201302. [DOI] [PubMed] [Google Scholar]
  9. Hakulinen T. Cancer survival corrected for heterogeneity in patient withdrawal. Biometrics. 1982 Dec;38(4):933–942. [PubMed] [Google Scholar]
  10. Joensuu H., Toikkanen S. Comparison of breast carcinomas diagnosed in the 1980s with those diagnosed in the 1940s to 1960s. BMJ. 1991 Jul 20;303(6795):155–158. doi: 10.1136/bmj.303.6795.155. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Levi F., Randimbison L., Te V. C., Franceschi S., La Vecchia C. Trends in cancer survival in Vaud, Switzerland. Eur J Cancer. 1992;28A(8-9):1490–1495. doi: 10.1016/0959-8049(92)90551-c. [DOI] [PubMed] [Google Scholar]
  12. Miller B. A., Feuer E. J., Hankey B. F. Recent incidence trends for breast cancer in women and the relevance of early detection: an update. CA Cancer J Clin. 1993 Jan-Feb;43(1):27–41. doi: 10.3322/canjclin.43.1.27. [DOI] [PubMed] [Google Scholar]
  13. Nab H. W., Voogd A. C., Crommelin M. A., Kluck H. M., vd Heijden L. H., Coebergh J. W. Breast cancer in the southeastern Netherlands, 1960-1989: trends in incidence and mortality. Eur J Cancer. 1993;29A(11):1557–1559. doi: 10.1016/0959-8049(93)90294-p. [DOI] [PubMed] [Google Scholar]
  14. Sant M., Gatta G., Micheli A., Verdecchia A., Capocaccia R., Crosignani P., Berrino F. Survival and age at diagnosis of breast cancer in a population-based cancer registry. Eur J Cancer. 1991;27(8):981–984. doi: 10.1016/0277-5379(91)90263-d. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES